![Chris Wasden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Wasden
Consultant / Advisor chez
37celsius Capital Partners LLC
Profil
Chris Wasden is currently an Advisory Board member at 37celsius Capital Partners LLC.
He was previously the CEO and President of Tympany, Inc. in 2005, Chairman and CEO of SimplexityMD, Inc. in 2006, and a Thought Leader at GEN3 Partners, Inc. in 2001.
Wasden received his undergraduate degree from Brigham Young University in 1985, his MBA from Anderson School of Management in 1987, and his doctorate from George Washington University in 2009.
Postes actifs de Chris Wasden
| Sociétés | Poste | Début |
|---|---|---|
37celsius Capital Partners LLC
 37celsius Capital Partners LLC Investment ManagersFinance 37celsius Capital Partner invests in companies across the globe primarily in North America with USD 5 - 50 million in revenue. The firm focuses on healthcare technology, services and data. It participates in growth and buyout transactions with investment size ranging from USD 20 - 50 million. It also takes controlling interest. | Consultant / Advisor | - |
Anciens postes connus de Chris Wasden
| Sociétés | Poste | Fin |
|---|---|---|
SimplexityMD, Inc.
 SimplexityMD, Inc. Investment ManagersFinance SimplexityMD focuses on investments in the life science technology sector with emphasis diagnostic and medical devices and tools (DMT). Within the DMT sector, the firm focuses on the aesthetics, cardiovascular and orthopedics areas. They invest primarily in companies located in the Houston, Texas metropolitan area. SimplexityMD typically invests up to $3 million per company. The firm prefers to make controlling investments and to take seats on their portfolio companies' boards of directors. SimplexityMD usually exits their investments within 5 to 7 years. | Corporate Officer/Principal | 02/01/2006 |
Tympany, Inc.
 Tympany, Inc. Medical SpecialtiesHealth Technology Manufactures advanced digital hearing aids | President | 30/09/2005 |
GEN3 Partners, Inc.
 GEN3 Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides world-class product, process and packaging innovation services | Corporate Officer/Principal | 30/04/2001 |
Formation de Chris Wasden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tympany, Inc.
Tympany, Inc. Medical SpecialtiesHealth Technology Manufactures advanced digital hearing aids | Health Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GEN3 Partners, Inc.
GEN3 Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides world-class product, process and packaging innovation services | Commercial Services |
SimplexityMD, Inc.
SimplexityMD, Inc. Investment ManagersFinance SimplexityMD focuses on investments in the life science technology sector with emphasis diagnostic and medical devices and tools (DMT). Within the DMT sector, the firm focuses on the aesthetics, cardiovascular and orthopedics areas. They invest primarily in companies located in the Houston, Texas metropolitan area. SimplexityMD typically invests up to $3 million per company. The firm prefers to make controlling investments and to take seats on their portfolio companies' boards of directors. SimplexityMD usually exits their investments within 5 to 7 years. | Finance |
Anderson School of Management
 Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
37celsius Capital Partners LLC
37celsius Capital Partners LLC Investment ManagersFinance 37celsius Capital Partner invests in companies across the globe primarily in North America with USD 5 - 50 million in revenue. The firm focuses on healthcare technology, services and data. It participates in growth and buyout transactions with investment size ranging from USD 20 - 50 million. It also takes controlling interest. | Finance |
